Tali-anne A. Szwebel

27, Rue Du Faubourg Saint Jacques, 
Paris, FR 
27, Rue Du Faubourg Saint Jacques, 
Paris, FR 

Overview

Tali-anne Szwebel practices practicing medicine in Paris, France.

Their clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), Pulmonary Embolism, and Dendritic Cell Tumor.

They are actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 2 clinical trials.

Locations

27, Rue Du Faubourg Saint Jacques, Paris, 75014, France
Other Locations
Eu, France
Paris Est Créteil University, 51 Avenue Du Maréchal De Lattre De Tassigny, Creteil, 94000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Calprotectin Involvement in Emergency Hematopoiesis Observed in Severe COVID-19
Calprotectin Involvement in Emergency Hematopoiesis Observed in Severe COVID-19
Enrollment Status: Withdrawn
Publish Date: March 12, 2026
Intervention Type: Biological
Study Phase: Not Applicable
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Enrollment Status: Completed
Publish Date: July 05, 2022
Intervention Type: Drug
Study Drug: Enoxaparin
Study Phase: Phase 3
View 1 Less Clinical Trial

31 Total Publications

Multiple thrombosis in a 54-year-old man
Multiple thrombosis in a 54-year-old man
Journal: La Revue de medecine interne
Published: July 03, 2025

Frequently Asked Questions about Tali-anne A. Szwebel

Is Tali-anne A. Szwebel a top-rated expert for COVID-19?

MediFind is an objective health platform that identifies experts based on real-world data. Tali-anne A. Szwebel is classified as an Experienced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tali-anne A. Szwebel participate in research or clinical trials?

Yes. Tali-anne A. Szwebel has published 31 articles and abstracts on conditions like COVID-19. You can view a list of Tali-anne A. Szwebel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Szwebel's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile